(Q42246305)

19 October 2017

HER2 expression in renal cell carcinoma is rare and negatively correlated with that in normal renal tissue (English)

1 reference

19 October 2017

1 reference

Huili Wang

1 reference

19 October 2017

Chengyi Liu

1 reference

19 October 2017

Jun Han

1 reference

19 October 2017

Lin Zhen

1 reference

19 October 2017

Tao Zhang

1 reference

19 October 2017

Xiaoli He

1 reference

19 October 2017

Enci Xu

1 reference

19 October 2017

Mengqiang Li

1 reference

19 October 2017

23 May 2012

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

194-198

1 reference

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial.

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccine

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

Interferon in metastatic renal cell carcinoma.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

HER-2/neu signal transduction in human breast and ovarian cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

P53 and her-2 alterations in renal cell carcinoma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402757

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes

17 August 2018

1 reference

12 December 2020

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

12 December 2020

Amplification and expression of EGFR and ERBB2 in Wilms tumor

1 reference

12 December 2020

Gene amplification and overexpression of HER2 in renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3892/OL.2012.727

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

22844352

1 reference